CIK 0001822791 · Non-accelerated filer<br>Smaller reporting company
Clene Inc.
Sign in to watch- Ticker
- CLNN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 852828339
- Phone
- 801-676-9695
- Business address
- 6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY, UT, 84121
- Former names
- Chelsea Worldwide Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 29 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-03 | Jacobovitz Shalom Director | Grant or award · Stock Options (Right to buy) | +7,400 | 7,400 | ||
| 2022-02-03 | Gay Jonathon Director | Grant or award · Stock Options (Right to buy) | +5,473 | 5,473 | ||
| 2022-02-01 | BROWN MORGAN R Chief Financial Officer | Grant or award · Stock Options (Right to buy) | +250,000 | 250,000 | ||
| 2022-02-01 | General Resonance LLC 10% owner | Sale | −101,352 | $2.96 | $300K | 15,874,921 |
| 2022-02-01 | MATLIN DAVID J Director | Purchase | +101,352 | $2.96 | $300K | 1,597,749 |
| 2022-01-20 | WILCOX REED N Director | Option exercise | +253,000 | $0.15 | $38K | 300,233 |
| 2022-01-20 | WILCOX REED N Director | Option exercise · Stock Options (Right to buy) | −253,000 | 274,911 | ||
| 2021-12-31 | Ugwumba Chidozie Director | Other acquisition | +4,528,809 | 4,528,809 | ||
| 2021-12-10 | MATLIN DAVID J Director | Purchase | +15,000 | $4.87 | $73K | 1,496,397 |
| 2021-12-09 | MATLIN DAVID J Director | Purchase | +40,000 | $5.00 | $200K | 1,481,397 |
| 2021-12-08 | MATLIN DAVID J Director | Purchase | +5,000 | $4.93 | $25K | 1,441,397 |
| 2021-12-06 | MATLIN DAVID J Director | Option exercise | +12,500 | $0.01 | $125 | 1,436,397 |
| 2021-12-06 | MATLIN DAVID J Director | Option exercise | +50,000 | $0.01 | $500 | 150,000 |
| 2021-12-06 | MATLIN DAVID J Director | Option exercise · Warrants (Right to buy) | −12,500 | 0 | ||
| 2021-12-06 | MATLIN DAVID J Director | Option exercise · Warrants (Right to buy) | −50,000 | 0 | ||
| 2021-11-16 | MATLIN DAVID J Director | Purchase | +20,000 | $5.26 | $105K | 1,423,897 |
| 2021-11-15 | MATLIN DAVID J Director | Purchase | +15,000 | $5.71 | $86K | 1,403,897 |
| 2021-11-12 | MATLIN DAVID J Director | Purchase | +10,000 | $5.37 | $54K | 1,388,897 |
| 2021-11-04 | Ugwumba Chidozie Director | Grant or award · Stock Options (Right to buy) | +3,441 | 3,441 | ||
| 2021-11-04 | Mortenson Mark Chief Science Officer | Grant or award · Stock Options (Right to buy) | +200,000 | 200,000 |
Page 20 of 22 · 427 trades